Results 191 to 200 of about 2,343 (215)

Bacosides from Bacopa monnieri extract: An overview of the effects on neurological disorders

Phytotherapy Research, 2021
Uttpal Anand, Puja Ray, Samapika Nandy   +2 more
exaly  

Transcriptome-wide miRNA identification of Bacopa monnieri: a cross-kingdom approach

Plant Signaling and Behavior, 2020
Harshida Gadhavi, Maulikkumar Patel, Naman Mangukia   +2 more
exaly  

Where Is Bacosine in Commercially Available Bacopa monnieri?

Planta Medica, 2020
Corinna Urmann, Wolfgang Eisenreich, Herbert Riepl   +2 more
exaly  

Quantitative determination of the major saponin mixture bacoside A inBacopa monnieri by HPLC

Phytochemical Analysis, 2005
M Deepak, A Amit
exaly  

StandardizedBacopa monnieriextract ameliorates acute paraquat-induced oxidative stress, and neurotoxicity in prepubertal mice brain

Nutritional Neuroscience, 2016
Ravikumar Hosamani, Gokul Krishna, Muralidhara   +2 more
exaly  

Nexus between light and culture media on morphogenesis in Bacopa monnieri and saponin yield thereof

Heliyon, 2020
Akanksha Aggarwal, Ashwani Mathur
exaly  

Brine shrimp lethality assay of Bacopa monnieri

Phytotherapy Research, 2002
Amit Agarwal
exaly  

Evolution of phytonotropes: emphasis on Bacopa Monnieri

Memostim® is a phytonootropic agent, containing standardized Bacopa Monnieri (BM) extract (150 mg per capsule) and Ginkgo biloba extract (120 mg per capsule), providing the whole daily dose of both components. Memostim® is registered in United Kingdom and sold in United States under trade name Memoboost®.
openaire   +1 more source

Brahmi (Bacopa monnieri)

2002
openaire   +1 more source

Bacopa monnieri Increases Cerebral Blood Flow in Rat Independent of Blood Pressure

Phytotherapy Research, 2013
Natakorn Kamkaew, C Norman Scholfield, Kornkanok Ingkaninan   +2 more
exaly